Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...
(NASDAQ:MRNA) today provided an update on regulatory submissions for its investigational seasonal influenza vaccine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback